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Nono is a component of the para-speckle, which
stores and processes RNA. Mouse embryonic stem
cells (mESCs) lack para-speckles, leaving the func-
tion of Nono in mESCs unclear. Here, we find that
Nono functions as a chromatin regulator cooperating
with Erk to regulate mESC pluripotency. We report
that Nono loss results in robust self-renewingmESCs
with epigenomic and transcriptomic features resem-
bling the 2i (GSK and Erk inhibitors)-induced ‘‘ground
state.’’ Erk interacts with and is required for Nono
localization to a subset of bivalent genes that have
high levels of poised RNA polymerase. Nono loss
compromises Erk activation and RNA polymerase
poising at its target bivalent genes in undifferentiated
mESCs, thus disrupting target gene activation and
differentiation. These findings argue that Nono col-
laborates with Erk signaling to regulate the integrity
of bivalent domains and mESC pluripotency.INTRODUCTION
Mouse embryonic stem cells (mESCs) cultured under traditional
serum/LIF conditions are naive but ‘‘metastable,’’ a phenome-
non characterized by heterogeneous expression of pluripotency
factors, such as Nanog, Klf4, and Tbx3 (Chambers et al., 2007;
Dan et al., 2013; Festuccia et al., 2012; Filipczyk et al., 2015; Ha-
tano et al., 2005; Kalmar et al., 2009; Niwa et al., 2009; Singh
et al., 2007; Torres-Padilla and Chambers, 2014). This heteroge-
neity reflects distinct differentiation potentials of individual
mESCs. Those expressing lower levels of pluripotency factors
are considered more prone to differentiation (primed), whereasCell
This is an open access article under the CC BY-Ncells expressing higher levels of these factors have more robust
self-renewal capability. However, whenmESCs are cultured with
inhibitors of the Mek/Erk and Gsk3b signaling pathways (2i,
PD03 for Mek/Erk, and CHIR for Gsk3b), this heterogeneity is
reduced, resulting in mESCs with more homogeneous and
higher expression levels of pluripotency factors, such as Nanog
and Klf4, thus resembling the in vivo, ‘‘ground-state’’ state (Mar-
tello and Smith, 2014; Nichols and Smith, 2009;Wray et al., 2010;
Ying et al., 2008). Despite extensive epigenomic and gene
expression analyses of mESCs under different culture condi-
tions, mechanisms by which the ERK pathway regulates stem
cell pluripotency remain incompletely understood.
Recently, Erk, an important kinase downstream of Mek, has
been identified as associating with a subset of bivalent genes
in mESCs under traditional serum/LIF cultures (Tee et al.,
2014). At these bivalent regions, activated Erk (phosphorylated)
mediates phosphorylation of serine 5 in the C-terminal domain
(CTD) of RNA polymerase II (RNAPIICTD), and helps keep
RNAPII in a poised state (Tee et al., 2014). Mek inhibition using
PD03 results in a loss of Erk activation, Erk dissociation from
chromatin, and altered RNAPII activity at bivalent targets. This
is accompanied by a phenotypic switch to a more robust self-re-
newing state, similar to the ground-state pluripotency (Kunath
et al., 2007; Tee et al., 2014; Ying et al., 2008). These findings
suggest an intrinsic connection between the chromatin states
of the Erk-bound bivalent regions and the differential pluripo-
tency potentials of mESCs. Therefore, understanding how inac-
tivation of Erk leads to more robust self-renewal and reduced
differentiation potentials of mESCs will give significant insight
into stem cell biology.
Nono (aka Nrb54 and P54nrb) was initially identified as a non-
POU-domain-containing, octamer-binding protein (Dong et al.,
1993; Yang et al., 1993). Nono binds both DNA and RNA,
possibly via its helix-turn-helix (HTH) and the RNA recognition
motif (RRM) domains, and has been suggested to regulateReports 17, 997–1007, October 18, 2016 ª 2016 The Authors. 997
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
transcription (Dong et al., 1993; Park et al., 2013; Yang et al.,
1993). In differentiated cells, Nono, together with Pspc1, Psf,
and a scaffolding non-coding RNA, Neat1, forms the nuclear
para-speckle structure, known to regulate RNA processing, nu-
clear retention of hyperedited mRNAs, and stress responses
induced by viral infection and DNA damage (Clemson et al.,
2009; Fox et al., 2002; Fox and Lamond, 2010; Hutchinson
et al., 2007; Li et al., 2009; Sunwoo et al., 2009). However, the
para-speckle structure is absent in human embryonic stem cells
(hESCs) and mESCs, possibly due to the lack of sufficient Neat1
(long isoform) expression (Ghosal et al., 2013), suggesting that
Nono may play a para-speckle-independent role in undifferenti-
ated ESCs. Here, we report that Nono acts as an Erk cofactor
to regulate mESC self-renewal and differentiation. Specifically,
we show that Nono physically interacts with Erk and co-localizes
with Erk to a subset of development-related, bivalent genes.
Loss of Nono leads to impaired Erk activation and RNA polymer-
ase II C-terminal domain serine 5 phosphorylation (RNAPIIS5P)
at Nono/Erk-bound bivalent genes, and compromised activation
of these genes during retinoic acid (RA)-induced differentiation.
Inactivation of Erk evicts Nono from chromatin. Nono-null cells
behave similarly to mESCs cultured under 2i conditions or with
PD03, i.e., they exhibit increased expression of pluripotency-
associated factors, are more self-renewing, and are more
resistant to differentiation. Molecular analyses also revealed
substantial epigenomic and transcriptomic similarities between
Nono knockout (KO) and 2i ground-state or PD03-treated
mESCs. Taken together, our findings suggest that Nono is a
critical regulator of bivalent domains and mESC pluripotency,
providing insight into the molecular mechanisms that balance
self-renewal and differentiation.
RESULTS
Nono KO mESCs Show Increased Expression of Nanog
and KLF4 with Enhanced Self-Renewal Capacity
As discussed, the para-speckle structure is absent in mESCs,
but Nono nonetheless is expressed and has been suggested
to regulate transcription of Oct4 (Park et al., 2013), raising
the possibility that Nono may play a role in regulating mESC
pluripotency. To investigate this possibility, we first generated
two independent Nono KO (KO1 and KO2) mESC lines using
the clustered regularly interspaced short palindromic repeats
(CRISPR) technology (Figures 1A and S1A). Interestingly,
Nono KO cells formed more compacted alkaline phospha-
tase-positive colonies with a greatly reduced number of differ-
entiated cells (Figure S1B, middle and right panels; Figures
1B and 1C, middle panels), suggesting an enhanced clonal
self-renewal capacity. Importantly, such phenotypic changes
were largely rescued by reintroduction of wild-type Nono, indi-
cating that the phenotype is due to the loss of Nono (Figures 1B
and 1C, right panels).
mESC self-renewal is governed by a network of pluripotency-
associated factors, including Nanog and Oct4. The Nono KO
mESC phenotype prompted us to investigate whether Nono
regulates the expression of these factors. As shown in Figures
1D and 1E, although Oct4 displayed only a modest increase at
mRNA level, Nanog expression, surprisingly, was significantly998 Cell Reports 17, 997–1007, October 18, 2016elevated in Nono KO mESCs at both the mRNA (Figure 1D)
and protein (Figure 1E) levels. Furthermore, although Nanog
expression levels vary (heterogeneously expressed) among
individual wild-type mESCs, Nono KO cells express increased
Nanog and have a reduced Nanog-negative population as
shown by both immunofluorescence and fluorescence-activated
cell sorting (FACS) analyses (Figures 1F, left, and 1G). Consis-
tently, the expression of another pluripotent factor, Klf4, a down-
stream target of Nanog, also showed a similar change (Figures
1D and 1F, right). Importantly, the normal expression pattern of
Nanog and Klf4 was by and large rescued by re-expression of
wild-type Nono (Figures 1F, lower panels, and 1G), indicating
that the altered Nanog and Klf4 expression patterns were due
to the loss of Nono.
Previous studies showed that individual mESCs transition
between a high Nanog state with an enhanced self-renewal
capacity and a low Nanog state, in which cells are primed for
lineage specification (Abranches et al., 2014; Chambers et al.,
2007; Kalmar et al., 2009; Torres-Padilla and Chambers,
2014). Our finding that loss of Nono reduces the population
of Nanog-negative cells is consistent with the enhanced
self-renewal capability of Nono KO mESCs. Importantly, these
features resemble the ground-state mESCs cultured with
inhibitors of MEK and GSK3b (2i), which display increased
self-renewal capacity associated with increased and more
homogeneous expression of Nanog (Abranches et al., 2014;
Ying et al., 2008).
Nono KO mESCs Show an Epigenomic and
Transcriptomic Signature Similar to Ground-State
Pluripotency
Because the ‘‘2i ground state’’ has been linked to global epige-
nomic and transcriptomic changes, including a reduction of
H3K27me3 at bivalent genes, as well as a global reduction
of DNA methylation (Marks et al., 2012; Tee et al., 2014),
we next asked whether Nono KO cells also show these
changes. Through genome-wide chromatin immunoprecipita-
tion sequencing (ChIP-seq) analyses, we found a significant
reduction of H3K27me3 at bivalent genes, whereas H3K4me3
was largely unaffected, similar to 2i mESCs (Figure 2A). Along
the same line, we also found a global reduction of DNA methyl-
ation in Nono KO cells, resembling 2i ground state mESCs (Fig-
ure 2B), although the effect is milder (Figure 2B). Consistent with
the epigenomic similarities, Nono KO cells also shared a similar
gene expression profile as 2i mESCs (Figure 2C). Collectively,
our findings suggest that Nono loss leads to robust self-renewal
and epigenomic and transcriptomic re-patterning, resembling
those observed for mESCs cultured with 2i.
Genomic Distribution of Nono in mESCs
To address the mechanism of action of Nono in mESCs, we
sought to identify endogenous Nono-bound genomic regions
by ChIP-seq. This effort yielded 1,193 potential Nono binding
events, covering 598 genes, which appear to be enriched at
promoter regions (Figure 3A). Consistently, analyses of the
genomic distributions of Nono ChIP-seq signals across an
average reference sequence database gene and around TSSs
(transcription start sites) also showed Nono enrichment at
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Figure 1. Nono Loss Results in Enhanced Self-Renewal
(A) Immunoblot analyses of Nono and Lamin B (as control) in WT (E14Tg2a) and Nono KO ESC cell lines.
(B) Alkaline phosphatase (AP) staining of colonies formed 7 days post-plating (100 units/ml LIF) from the WT (E14Tg2a), Nono KO1, and Nono KO-rescued cells.
The scale bar represents 200 mm.
(C) Quantitation of colony types from the experiments shown in (B).
(D) RT-qPCR analyses of Oct4, Nanog, and Klf4 levels in WT (E14Tg2a) and two Nono KO cell lines.
(E) Immunoblot analyses of Nanog, Oct4, and Lamin B (as control) in WT (E14Tg2a) and two Nono KO cell lines.
(F and G) Immunofluorescence analyses (F) of Nanog (green, left panel), Klf4 (green, right panel), and Oct4 (red) expression, and quantitative flow cytometry
analysis (G) of Nanog expression, in WT (E14Tg2a), Nono KO1, and Nono KO-rescued cells. The scale bar represents 100 mm.
In (C) and (D), all data are represented as mean ± SD (n = 3); *p < 0.05; **p < 0.01, t test.promoters, with the highest signal density around TSSs (Fig-
ure 3B). That these are genuine Nono-binding events was
further confirmed using the two Nono KO mESC lines as nega-
tive controls (Figures 1A and 3C). Importantly, Gene Ontology
(GO) analysis identified a significant enrichment of Nono-bound
genes in the category of transcription regulation and develop-
mental genes (Figures S2A and S2B), including Pax9, Tbx3,
Cdx2, Gata4, as well as all Hox clusters of genes, which are
known to be decorated and regulated by bivalent domains
(Bernstein et al., 2006; Vastenhouw and Schier, 2012) (Fig-
ure 3D). Significantly, further bioinformatics analyses showed
that 63.7% (381/598) of Nono-bound genes are associated
with bivalent domains (Figures 3E, 3F, and S2C), suggesting
Nono may directly regulate mESC pluripotency through regu-
lating this subset of bivalent genes.Erk2 Interacts and Is Required for Nono Localization to a
Subgroup of Bivalent Genes
Although most Nono-bound genes carry bivalent modifications,
only a small portion (12%, 381/3,104) of total mESC bivalent
genes are bound by Nono (Figures 3F and S2C), suggesting
that bivalent state alone does not define Nono chromatin associ-
ation. Interestingly, further bioinformatics analyses found that
more than two-thirds of Nono binding events (68.3%, 815/
1,193) are shared by Erk2, whereas reciprocally one-third
(33.3%, 815/2,445) of Erk2-binding events are shared by Nono
(Figure 4A). However, the actual degree of overlap might be
higher as our ChIP-seq is limited by the detection sensitivity of
the Nono antibody. Supporting this, we were able to detect
Nono binding by the more sensitive ChIP-qPCR at all six
randomly selected Erk2 targets, which were otherwise negativeCell Reports 17, 997–1007, October 18, 2016 999
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Figure 2. Nono Loss Results in Transcriptomic Signature Resembling Ground-State Pluripotency
(A) Heatmap analysis of H3K4me3 and H3K27me3 ChIP-seq data from E14Tg2a and Nono KO1 ESCs at 3,104 annotated bivalent genes. The ChIP-seq signals
are displayed in the distance of ±10 kb to TSS. Color scale represents normalized read density.
(B) Global DNAmethylation in the parental E14Tg2a, Nono KO1, and 2i-treated E14Tg2amESCsmeasured by dot blot (100 ng per dot, left) and quantitative high-
performance liquid chromatography (HPLC) (right).
Data are represented as mean ± SD (n = 3); *p < 0.05; **p < 0.01, t test.
(C) Left: heatmap analysis of total differentially regulated genes (fold R 1.5; fragments per kilobase of transcript per million mapped reads [FPKM] > 0.5) in
2i-treated E14Tg2a mESCs and Nono KO1 mESCs compared with E14Tg2a, ranked by genes with altered expression in 2i-treated E14Tg2a (from up to down).
Right: Venn diagram illustrating a significant overlap between 2i and Nono KO1 upregulated and downregulated genes. p values are determined by the
hypergeometric distribution test.for Nono binding based on the ChIP-seq signals (Figure S2D).
Nonetheless, these data revealed a significantly more extensive
overlap between Nono- and Erk2-bound chromatin locations, as
opposed to the general pool of bivalent domains, in mESCs. Our
further analyses showed that the majority of the 815 Nono and
Erk2 co-bound events are located in bivalent genes (85.1%,
320/376) (Figures 4B and S2C). Importantly, Erk signaling is crit-
ical for mESC self-renewal and differentiation, and activated Erk
has recently been shown to phosphorylate serine 5 in the CTD of
RNAPII to keep RNAPII at the Erk-bound bivalent regions at a
poised state (Kunath et al., 2007; Tee et al., 2014; Ying et al.,
2008). Consistently, most of Nono-bound genes also tracked
with RNAPIIS5P (Figures 4C and S2C), and the interactions
among Nono, Erk2, and RNAPII5SP in mESC extracts were
readily detectable by co-immunoprecipitation (Figures 4D for1000 Cell Reports 17, 997–1007, October 18, 2016endogenous interactions, and 4E for interactions between
Nono and ectopic FLAG-tagged Erk2). To exclude the possibility
of chromatin-mediated interactions between Nono and Erk2, we
turned to in vitro pull-down assays. As shown in Figure 4F, re-
combinant GST-tagged Erk2, and FLAG-tagged Nono purified
from Escherichia coli and Sf9 insect cells, respectively, inter-
acted with each other in vitro, suggesting a direct interaction.
Taken together, these results suggest that Nono co-localizes
and interacts with Erk2, thus identifying Nono as a bivalent
domain component.
To understand howNono is localized to bivalent chromatin, we
asked whether Nono chromatin occupancy is dependent on Erk.
Importantly, we found that inhibition of Erk1/2 by two indepen-
dent short hairpin RNA (shRNA) pairs (Figure 4G) significantly
reduced Nono chromatin association, as shown by ChIP-qPCR
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Figure 3. Nono Localizes to a Subset of Bivalent Domains in mESCs
(A) Genome-wide distribution of Nono binding events in mES cells. Random peaks were generated as control to show fold of enrichment.
(B) Average Nono ChIP-seq and input signals on Nono-bound genes. p values by ANOVA test.
(C) Nono ChIP-qPCR analyses at three selected bivalent genes andGapdh locus (as control) in WT (E14Tg2a) and two Nono KO ESC lines. Data are represented
as mean ± SD (n = 3); **p < 0.01, t test.
(D) UCSC snapshots of Nono, H3K4me3, and H3K27me3 ChIP-seq signals at four representative bivalent regions.
(E) Heatmap analyses of Nono, H3K4me3, and H3K27me3 ChIP-seq signals ranked by Nono ChIP-seq intensities over target TSSs.
(F) Venn diagrams showing significant overlap between Nono-bound genes and bivalent genes in mESCs. p values by hypergeometric distribution test.at three target regions (Figure 4H). We further asked whether
activation of Mek/Erk signaling is required for Nono bivalent
domain localization. As shown in Figure 4I (left), PD03 treatment
caused not only a reduction of Erk2 binding as previously re-
ported (Tee et al., 2014) but also a significant reduction of
Nono binding at these bivalent genes (Figure 4I, right). These
data indicate that Erk and activatedMek/Erk signaling play a crit-
ical role in Nono chromatin localization.
Nono Loss Results in Impaired Erk Activation
The fact that Nono and Erk2 interact and co-localize at a subset
of bivalent genes prompted us to investigate whether Nono plays
a role in the regulation of Erk in mESCs. Interestingly, we found
that, although global levels of Erk1/2 were not altered in the
Nono KO cells, the active form of Erk1/2 (pErk1/2) was signifi-
cantly reduced (Figure 5A), indicating that Erk activation was
impaired in the absence of Nono. Consistently, we further found
a substantial local reduction of pErk1/2, but not total Erk2, at
bivalent genes (Figure 5B), suggesting that the activation but
not chromatin occupancy of Erk is regulated by Nono. This is
similar but not identical to Mek/Erk inactivation mediated by
PD03, which results in an impaired chromatin occupancy of
both phosphorylated Erk as well as total Erk protein (Tee et al.,
2014). Consistently, we found that Nono KO mESCs showed a
similar expression profile to that of the PD03-treated mESCs
(Figure 5C), with significant overlaps of both upregulated and
downregulated genes. We were able to confirm by RT-qPCRthis same trend of regulation by Nono versus PD03 at a few
selected Nono- and Erk-co-bound bivalent genes (Figure S3A).
Interestingly, we found that PD03 further increased the expres-
sion levels of Nanog and Klf4 in the Nono KO cells and further
reduced Nanog-negative population as shown by RT-qPCR
and FACS analyses, suggesting additive effects of Nono loss
and PD03 treatment (Figures S3B and S3C).
Nono Is Required for RNAPIIS5 Phosphorylation at Its
Target Bivalent Genes and Their Activation during
Differentiation
As Nono co-localizes with Erk2 and is required for Erk activation
at a subset of bivalent genes, we next asked whether Nono loss
leads to an impaired RNAPIIS5P at its bivalent target genes due
to a defect in Erk activation. Through genome-wide ChIP-seq
analyses, we found the highest level of RNAPIIS5P at Nono/
Erk-bound bivalent genes, as well as a significant reduction of
RNAPIIS5P but not total RNAPII at bivalent genes in Nono KO
mESCs (Figure 6A), similar to Erk-inhibited mESCs (Tee et al.,
2014). Interestingly, a more significant reduction of RNAPIIS5P
was observed at the top 300 Nono-bound bivalent genes,
most of which are co-bound by Erk, when compared to the
unbound ones (Figure 6B), supporting a direct mode of action
of Nono at its target bivalent genes. However, a much milder
reduction of RNAPIIS5P at the Nono/Erk-unbound bivalent
genes was also detected, suggesting a possible involvement
of additional mechanisms (Figure 6B).Cell Reports 17, 997–1007, October 18, 2016 1001
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Figure 4. Nono Interacts with and Requires Erk2 for Its Localization at a Subgroup of Bivalent Genes
(A and B) Venn diagrams showing significant overlap between Nono and Erk2 binding events in mESCs (A), and that the majority of Nono/Erk2-co-bound genes
are bivalent genes (B). p values by Fisher exact test.
(C) UCSC snapshots of Nono, Erk2, and RNAPIIS5P ChIP-seq signals at the Hox C cluster. Erk2 data are adapted from published data (Tee et al., 2014).
(D and E) Co-immunoprecipitation analyses showing the interaction between endogenous Nono, RNAPIIS5P, and Erk2 (D), FLAG-Erk2 and Nono (E).
(F) In vitro pull-down analyses using recombinant GST-Erk2 and FLAG-Nono purified from E. coli and insect Sf9 cells, respectively.
(G) Western blot showing Erk1/2 levels for shScr and Erk1/2 depleted (shErk1/2#1 and shErk1/2#2) ESCs.
(H) Nono ChIP qPCR on a few selected target genes (indicated at the bottom) in scramble control (shScr) and Erk1/2-depleted ESCs. Error bars represent
SD; n = 3.
(I) Erk2 and Nono ChIP qPCR in control and PD03 treated mESCs. Error bars represent SD; n = 3.
In (H) and (I), all qPCR data are represented as mean ± SD (n = 3); *p < 0.05; **p < 0.01, t test.Because the expression of many bivalent genes needs to be
activated upon differentiation, we further investigated Nono
function in bivalent gene activation upon RA-induced differenti-
ation. By RNA sequencing (RNA-seq), we found that the fold
of activation of the top 300 Nono-bound bivalent genes, most
of which are also co-bound by Erk, is significantly higher
than the unbound controls (Figure 6C, compare column 1 to 3,
p = 1.35e-08), possibly due to the already higher level of
RNAPIIS5P before differentiation (Figures 6A and 6B). Interest-
ingly, compared to the unbound ones, the activation of Nono-
bound bivalent genes is more significantly compromised upon
differentiation in Nono KO cells (Figure 6C, compare left panel,
p = 7.98e-11, to right panel, p = 0.2413). The activation of
some of these target genes remained impaired even at day 3 af-
ter the initiation of differentiation, suggesting a sustained defect
in transcriptional activation in Nono KO cells during differentia-
tion (Figure 6D).1002 Cell Reports 17, 997–1007, October 18, 2016Nono Loss Compromises mESC Differentiation
Wenext investigatedwhetherNono-null cells alsoexhibit compro-
mised ability to undergo differentiation as a result of an impaired
Erk activity and compromised activation of Nono/Erk co-bound
bivalent genes. We first used embryonic body (EB) formation
assay to investigate the differentiation potential of the parental,
the Nono KO, and the Nono KO with a Nono rescuing construct.
Consistently, we found that EBs developed from the Nono KO
mESC cells were often much smaller and displayed disorganized
structures, compared to the parental control (Figure 7A, compare
the middle to the left, p = 0.03). In addition to the compromised
activation of some developmental genes such as Cdx2 and
Sox17 (Figure 7B), Nono KO cells also showed a compromised
repression of the pluripotent genes, including Nanog, Sox2, and
Oct4 (Figure 7C), suggesting a comprised differentiation. Impor-
tantly, these defects can be largely rescued by reintroducing
wild-type Nono (Figures 7A–7C), indicating on-targeting effects.
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Figure 5. Nono Loss Results in Impaired Erk Activity
(A) Western blot analyses of Nono, Erk1/2, phospho-Erk1/2 (pErk1/2), and Lamin B (as control) levels in the indicated cell lines.
(B) ChIP-qPCR analyses of Erk2 and pErk1/2 chromatin occupancies at selected genes in WT (E14Tg2a) and two Nono KO mESCs. Data are represented as
mean ± SD (n = 3); *p < 0.05; **p < 0.01, t test.
(C) Left: heatmap analysis of total differentially regulated genes in Nono KO1- and PD03-treated E14Tg2a mESCs compared with E14Tg2a (fold R 1.5;
FPKM > 0.5), ranked by genes with altered expression in Nono KO1 (from up to down). Right: Venn diagram illustrating the overlap between Nono KO1 and PD03
upregulated and downregulated genes. p values are determined by the hypergeometric distribution test.Wefurther investigated the roleofNono inamonolayerneuronal
stem cell (NSC) differentiation process. As shown in Figure 7D,
Nono loss significantly compromised neural differentiation,
as evidenced by the presence of much fewer cells with b-III-
Tubulin-positive axonal processes. Consistently, most Nono KO
cells retained high and persistent expression of Oct4 even at
day 10 post-differentiation induction, whereas in most of the con-
trol mESC cells at this time point Oct4 should have already been
largely silenced (Figure 7D). Supporting the phenotypic analysis,
we also found that suppression of the expression of pluripotency
factors and activation of neuronal markers were significantly
compromised in Nono KO cells during differentiation (Figure 7E).
To further confirm Nono function in differentiation in vivo, we
employed mouse teratoma model. Although both WT and
Nono KO cells formed teratomas in 5 weeks, the Nono KO tera-
tomas weremuch bigger than the controls (Figure S4A), and with
significantly more Oct4-positive and fewer b-III-Tubulin-positivecells (Figure 7F), suggesting a compromised differentiation.
Additionally, although Nono KO teratomas were able to develop
all three germ layers (Figure S4B), they by and large gave rise to
much smaller ectoderm-derived, keratinized epithelium tissues
(Figure S4B, left) and fewer mesoderm-derived muscle tissues
(Figure S4B, middle), but no obvious alterations of endoderm-
derived intestinal epithelium tissues (Figure S4B, right).
It is important to note that, consistent with our molecular find-
ings that Nono and Erk reciprocally regulate each other, Nono
KO mESCs behaved similarly as the PD03-treated (Figures
S4C and S4D) and Erk2 KO mESCs (Kunath et al., 2007), in our
EB and monolayer NSC differentiation assays.
Taken together, we find that Nono KOmESCs displayed many
similarities to 2i ground state and PD03-treated mESCs in
terms of the robust self-renewal capability, resistance to differ-
entiation, as well as epigenomic and transcriptomic features.
Mechanistically, Nono localization to the Erk2-marked bivalentCell Reports 17, 997–1007, October 18, 2016 1003
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Figure 6. Nono Is Required for RNAPIIS5P at Its Target Bivalent Genes and Their Activation during Differentiation
(A) Heatmap analysis of Nono, Erk2, RNAPIIS5P, and total RNAPII ChIP-seq data from E14Tg2a and Nono KO1 ESCs ranked by Nono ChIP-seq signals at 3,104
annotated bivalent genes. The ChIP-seq signals are displayed in the distance of ±10 kb to TSS. Color scale represents normalized read density.
(B) Signal plot analyses showing the reduction of RNAPIIS5P at the top 300 Nono-bound (left) and 300 unbound bivalent genes. p values by ANOVA test.
(C) Fold of bivalent gene activation (presented as Log2) in WT (E14Tg2a) and Nono KO1 cells 1 day post-RA-induced differentiation. Expression data from RNA-
seq. Left: top 300 bivalent genes bound by Nono. Right: a control set of 300 bivalent genes with the lowest Nono binding intensities. p values by Student’s t test
(two-sample t tests).
(D) RT-qPCR analyses of selected Nono target gene expression in the indicated cell lines at different time points after the initiation of RA induced differentiation.
Data are represented as mean ± SD (n = 3); *p < 0.05; **p < 0.01, t test.domains requires Erk, and on the other hand, Nono is also
involved in Erk activation and bivalency integrity, thus revealing
a reciprocal regulation between Nono and Erk. Importantly,
Nono/Erk-bound bivalent genes undergo robust activation
upon differentiation, which is likely to be dependent on Nono/
Erk-mediated RNAPIIS5P at the pluripotent state.
DISCUSSION
This study identifies Nono as a regulator of mESC pluripotency.
Loss of Nono in mESCs results in a ground-state-like pluripo-
tency, characterized by robust self-renewal with epigenomic
and transcriptomic features resembling those of 2i treatment or
Erk inhibition alone. Mechanistic analyses reveal that Nono func-
tions in Erk signaling, i.e., Nono interacts with and co-localizes
with Erk at a subset of bivalent genes with the highest level of
RNAPIIS5P. Loss of Nono blocks Erk activation and results in
reduced poised RNAPII at its target bivalent genes in undifferen-
tiated mESCs, compromised target gene activation upon differ-
entiation, and differentiation itself. Loss of Erk protein or inhibi-
tion of Mek/Erk signaling leads to Nono dissociation from
chromatin. Our data thus reveal a role for Nono at bivalent chro-
matin, where it works with Erk to regulate mESC pluripotency.1004 Cell Reports 17, 997–1007, October 18, 2016Nono and Erk in the Regulation of mESC Bivalent
Domain and Pluripotency
Our data indicate that Nono is necessary for Erk activation,
which would place Erk downstream of Nono and explain the sim-
ilarity of the phenotypic changes upon loss of Nono or Erk inac-
tivation. However, both chemical inhibition and genetic ablation
of Erk also result in Nono dissociation from chromatin, loss of
bivalent domain integrity, and upregulation of a subset of shared
target genes. Thus, these data collectively reveal a reciprocal
and positive reinforcement loop, and suggest that Nono and
Erk function together rather than hierarchically.
Our data also reveal that Nono/Erk-co-bound bivalent genes
show the highest RNAPIIS5P in comparison to the unbound
ones (Figure 6A). Importantly, this subset of bivalent genes are
also the ones that undergo stronger activation during differentia-
tion, and loss of Nono leads to compromised activation of these
genes (Figures 6C and 6D), perhaps due to loss of Erk-mediated
RNAPIIS5P before differentiation (Figures 6A and 6B). Although
we cannot fully exclude the possibility of indirect effects due to
compromised differentiation of Nono KO mESCs, we only
observed the impaired gene activation for Nono-bound bivalent
genes not unbound ones, favoring a specific mode of action.
These data indicate that Nono and Erk are required for
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Figure 7. Nono Loss Leads to Differentiation Defect
(A) Morphological analyses of EBs formed from the indicated cell lines at day 8 post-induction. The scale bar represents 100 mm. p values by t test.
(B) RT-qPCR analyses of Cdx2 and Sox17 expressions in the indicated cell lines at different time points after the initiation of EB differentiation. Data are rep-
resented as mean ± SD (n = 3); *p < 0.05, t test.
(C) Immunoblot analyses of pluripotency markers, Nanog, Sox2, and Oct4, from day 8 EBs formed from the indicated cell lines.
(D and E) Immunofluorescence analyses (D) of Oct4 (red) and b-III-Tubulin (green) proteins at day 10, and RT-qPCR analyses (E) of Rex1, b-III-Tubulin, andNestin
mRNAs at indicated point points, in mESCs induced toward NSC differentiation for 10 days. Cells were counterstained with DAPI (blue, D). The scale bar
represents 100 mm. Data are represented as mean ± SD (n = 3) in (E); *p < 0.05; **p < 0.01, t test.
(F) Immunofluorescence analysis of Oct4 and b-III-Tubulin in the teratomas from E14Tg2a and Nono KO1 cells. The scale bar represents 100 mm.RNAPIIS5P at a subset of bivalent genes in mESCs, and this pro-
cess sets up the poised transcriptional machinery needed for
later gene activation. This is consistent with the idea that bivalent
genes are subject to dynamic regulation, different from fully silent
genes. However, why theNono/Erk-co-bound but not all bivalent
genes are selected for such regulation and how the specificity is
achieved remain interesting questions for future investigation.
Nono and Para-speckle in Self-Renewing and
Differentiated Cells
As discussed earlier, Nono is an RNA binding protein and amajor
component of para-speckles. The main functions of para-
speckles are RNA processing, nuclear retention of mRNA, and
stress responses (Chen andCarmichael, 2009; Fox and Lamond,
2010). However, para-speckles are thought to exist in differenti-
ated cells, but not in ESCs, due to insufficient expression of the
scaffolding non-coding RNA, Neat1, suggesting that Nono mayfunction differently in mESCs (Ghosal et al., 2013; Mercer
et al., 2010; Standaert et al., 2014; West et al., 2014; Zeng
et al., 2014). Our finding that Nono functions as a bivalent chro-
matin factor in mESCs is consistent with this prediction.
Our study shows that Nono interacts and co-localizes with
Erk2 and RNAPIIS5P at bivalent genes inmESCs, whereas a pre-
vious study also reported that Nono binds both phosphorylated
and unphosphorylated RNAPII CTD at Ser5 (Emili et al., 2002).
This raises the possibility that Nono may not only interact with
poised RNAPII in mESCs but also play a role in gene activation
and mRNA processing upon differentiation. Supporting this,
we observed compromised activation of Nono/Erk-co-bound
bivalent genes in Nono KO cells during RA-induced differentia-
tion. Because Nono is reported to bind mRNAs and required
for mRNA processing in differentiation cells (Clemson et al.,
2009; Fox et al., 2002; Fox and Lamond, 2010; Hutchinson
et al., 2007; Li et al., 2009; Sunwoo et al., 2009), it is conceivableCell Reports 17, 997–1007, October 18, 2016 1005
that such a mechanism may be critical for Nono-bound bivalent
genes to produce mature mRNAs once mESCs leave the primed
state to differentiate. Whether such a mechanism is dependent
on functional para-speckles that are assembled after differentia-
tion will be another interesting question to address (Emili et al.,
2002; Kaneko et al., 2007; West et al., 2014). It will also be of
importance to evaluate whether this mechanism is conserved
in the regulation of ESCs of human and other species.
In summary, our findings highlight a function for Nono in
mESCs where it plays a critical role at the chromatin interface
to regulate Erk signaling, impacting the integrity of bivalent chro-
matin at developmental genes and mESC pluripotency.
EXPERIMENTAL PROCEDURES
Cell Culture and Cell Differentiation
mESCs were grown in standard ESC medium containing serum and 100 U/ml
LIF, unless otherwise stated. For the generation of Nono-rescued mESCs,
Nono open reading frame was cloned into pPB Flag-HA puromycin expression
vector. The Nono-rescued and vector control mESCs were maintained in
2 mg/ml puromycin.
Immunofluorescence, Flow Cytometry Analysis, and Co-
immunoprecipitation
mESC cells were seeded in 12-well plates at a density of 50K cells/well at 48 hr
before immunofluorescence examination.
Flow cytometry analysis of Nanog expression was carried out as previously
described (Festuccia and Chambers, 2011). Briefly, 23 105 cells were stained
with Nanog antibody (1:300; eBioMLc-51) and anti-rat conjugated to Cy3
(1:500), and 20K cells were analyzed for each sample.
Nuclear extracts used for co-immunoprecipitation were prepared from
mESC cells, and co-immunoprecipitation analyses were carried out as
described previously (Mendez and Stillman, 2000).
In Vitro Pull-Down Assay
FLAG-tagged Nono was purified from insect cells, and GST-tagged Erk2 pro-
teins were purified from E. coli. A total of 5 mg of FLAG-Nono and 5 mg of GST-
Erk2 proteins were incubated in 200-mL reaction system in binding buffer
(20 mM Tris-Cl, pH 7.4, 150 mM NaCl, and 0.1% Triton X-100) for 3 hr at
4C. FLAG-Nono and GST-Erk2 complex was captured using FLAG or GST
beads and then subjected to western blot analyses.
ChIP, ChIP-Seq, and Data Analyses
ChIP assay was performed as described elsewhere (Lan et al., 2007). The
precipitated DNA samples were analyzed using real-time quantitative PCR
(qPCR) and prepared for deep sequencing according to the manufacturer’s
guidelines (Guo et al., 2014 and Illumina). DNA deep-sequencing analyses
were performed at the Epigenetics Key Laboratory at Institutes of Biomedical
Sciences (IBS) of Fudan University (Shanghai, China). The animal protocols
were approved by the Animal Welfare Committee of Shanghai Medical Col-
lege, Fudan University.
For ChIP-seq data processing, the FASTQ data were mapped to mouse ge-
nome(mm9) using Bowtie, and significant enrichments (peaks) were identified
by MACS 1.4 using broad peak mode with a value of p% 1 3 105 and false
discovery rate (FDR)% 0.01 as a cutoff from the mapped reads (Zhang et al.,
2008). For Erk ChIP-seq, please refer to Sequence Read Archive: SRP028688.
A total of 3,104 bivalent genes are classified by the overlap of H3K4me3 and
H3K27me3 with mapping tags > 50 and fold enrichment > 8 compared to input
(Marks et al., 2012).
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